Carboplatin and paclitaxel as an initial treatment in patients with stage IVb cervical cancer: A report of 7 cases and a review of the literature

Journal of Gynecologic Oncology

Volumn 21, Issue 2, 2010, Pages 93-96

  Mabuchi, Seiji ^a   Morishige, Kenichirou ^a   Enomoto, Takayuki ^a   Kimura, Tadashi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Carboplatin; Cervical cancer; Paclitaxel; Stage IVb

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TOLERABILITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MEDICAL LITERATURE; MULTIPLE CYCLE TREATMENT; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE; UTERINE CERVIX CANCER;

EID: 77954519788     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2010.21.2.93     Document Type: Article

References (18)

1. Omura GA. Chemotherapy for stage IVB or recurrent cancer of the uterine cervix. J Natl Cancer Inst Monogr 1996; 21: 123-6.
2. Nishio S, Katsumata N, Matsumoto K, Tanabe H, Yonemori K, Kohno T, et al. Analysis of the clinicopathological prognosis of stage IVh cervical carcinoma. Oncol Rep 2008; 19: 497-503.
3. National Comprehensive Cancer Network. NCCN practice guideline in oncology 2008 [Internet]. Fort Washington: National Comprehensive Cancer Network; c2010 [cited 2010 Mar 20]. Available from: http://www.nccn.org/ professionals/physician-gls/f-guidelines.asp.
4. Moore DH, Blessing JA, McQuellon RP, Thaler HT, Cella D, Benda J, et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2004; 22: 3113-9.
5. McGuire WP 3rd, Arseneau J, Blessing JA, DiSaia PJ, Hatch KD, Given FT Jr, et al. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol 1989; 7: 1462-8.
6. Barbera L, Thomas G. Management of early and locally advanced cervical cancer. Semin Oncol 2009; 36: 155-69.
7. Long HJ 3rd. Management of metastatic cervical cancer: review of the literature. J Clin Oncol 2007; 25: 2966-74.
8. Long HJ 3rd, Bundy BN, Grendys EC Jr, Benda JA, McMeekin DS, Sorosky J, et al. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2005; 23: 4626-33.
9. Monk BJ, Sill MW, McMeekin DS, Cohn DE, Ramondetta LM, Boardman CH, et al. Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2009; 27: 4649-55.
10. Moore DH, Tian C, Monk BJ, Long HJ, Omura GA, Bloss JD. Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study. Gynecol Oncol 2010; 116: 44-9.
11. Coleman RL. The Gynecologic Oncology Group's role in the treatment of recurrent cervix cancer: current clinical trials. Gynecol Oncol 2008; 110(3 Suppl 2): S77-80.
12. Mabuchi S, Morishige K, Fujita M, Tsutsui T, Sakata M, Enomoto T, et al. The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy. Gynecol Oncol 2009; 113: 200-4.
13. Sit AS, Kelley JL, Gallion HH, Kunschner AJ, Edwards RP. Paclitaxel and carboplatin for recurrent or persistent cancer of the cervix. Cancer Invest 2004; 22: 368-73.
14. Secord AA, Havrilesky LJ, Carney ME, Soper JT, Clarke-Pearson DL, Rodriguez GC, et al. Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer. Int J Clin Oncol 2007; 12: 31-6.
15. Piver MS, Ghamande SA, Eltabbakh GH, O'Neill-Coppola C. First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix: a phase II study. Gynecol Oncol 1999; 75: 334-7.
16. Tinker AV, Bhagat K, Swenerton KD, Hoskins PJ. Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience. Gynecol Oncol 2005; 98: 54-8. (Pubitemid 40826418)
17. Moore KN, Herzog TJ, Lewin S, Giuntoli RL, Armstrong DK, Rocconi RP, et al. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer. Gynecol Oncol 2007; 105: 299-303. (Pubitemid 46590319)
18. US National Institutes of Health. ClinicalTrials.gov: a randomized phase III trial of paclitaxel plus cisplatin versus paclitaxel plus carboplatin in stage IVb, persistent, or recurrent cervical cancer [Internet]. Rockville: US National Institutes of Health; [cited 2010 Mar 20]. Available from: http://www.clinicaltrials.gov.